BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, Nie Y, Li M, Zhi F, Liu S, Amir A, González A, Tripathi A, Chen M, Wu GD, Knight R, Zhou H, Chen Y. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems 2018;3:e00188-17. [PMID: 29404425 DOI: 10.1128/mSystems.00188-17] [Cited by in Crossref: 85] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
2 Iablokov SN, Klimenko NS, Efimova DA, Shashkova T, Novichkov PS, Rodionov DA, Tyakht AV. Metabolic Phenotypes as Potential Biomarkers for Linking Gut Microbiome With Inflammatory Bowel Diseases. Front Mol Biosci 2020;7:603740. [PMID: 33537340 DOI: 10.3389/fmolb.2020.603740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cao WT, Fan YH, Lv B. Intestinal microbial markers for diagnosis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(3): 190-196 [DOI: 10.11569/wcjd.v27.i3.190] [Reference Citation Analysis]
4 Pilla R, Gaschen FP, Barr JW, Olson E, Honneffer J, Guard BC, Blake AB, Villanueva D, Khattab MR, AlShawaqfeh MK, Lidbury JA, Steiner JM, Suchodolski JS. Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. J Vet Intern Med 2020;34:1853-66. [PMID: 32856349 DOI: 10.1111/jvim.15871] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
5 Di Pierro F. Gut Microbiota Parameters Potentially Useful in Clinical Perspective. Microorganisms 2021;9:2402. [PMID: 34835527 DOI: 10.3390/microorganisms9112402] [Reference Citation Analysis]
6 Aldars-García L, Chaparro M, Gisbert JP. Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease. Microorganisms 2021;9:977. [PMID: 33946482 DOI: 10.3390/microorganisms9050977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Fontana A, Panebianco C, Picchianti-Diamanti A, Laganà B, Cavalieri D, Potenza A, Pracella R, Binda E, Copetti M, Pazienza V. Gut Microbiota Profiles Differ among Individuals Depending on Their Region of Origin: An Italian Pilot Study. Int J Environ Res Public Health 2019;16:E4065. [PMID: 31652705 DOI: 10.3390/ijerph16214065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
8 He H, Lin M, You L, Chen T, Liang Z, Li D, Xie C, Xiao G, Ye P, Kong Y, Zhou Y. Gut Microbiota Profile in Adult Patients with Idiopathic Nephrotic Syndrome. Biomed Res Int 2021;2021:8854969. [PMID: 33681383 DOI: 10.1155/2021/8854969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 He Y, Tiezzi F, Jiang J, Howard JT, Huang Y, Gray K, Choi J, Maltecca C. Use of Host Feeding Behavior and Gut Microbiome Data in Estimating Variance Components and Predicting Growth and Body Composition Traits in Swine. Genes 2022;13:767. [DOI: 10.3390/genes13050767] [Reference Citation Analysis]
10 Tierney BT, Yang Z, Luber JM, Beaudin M, Wibowo MC, Baek C, Mehlenbacher E, Patel CJ, Kostic AD. The Landscape of Genetic Content in the Gut and Oral Human Microbiome. Cell Host Microbe 2019;26:283-295.e8. [PMID: 31415755 DOI: 10.1016/j.chom.2019.07.008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 56] [Article Influence: 26.3] [Reference Citation Analysis]
11 Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front Nutr 2022;8:818902. [DOI: 10.3389/fnut.2021.818902] [Reference Citation Analysis]
12 Guo Y, Xu Y, Lin X, Zhen Z, Yi F, Guan H, Shi Q, Sun W, Yang A, Dong X, Wang J. Creutzfeldt-Jakob Disease: Alterations of Gut Microbiota. Front Neurol 2022;13:832599. [DOI: 10.3389/fneur.2022.832599] [Reference Citation Analysis]
13 Liu F, Lee SA, Riordan SM, Zhang L, Zhu L. Effects of Anti-Cytokine Antibodies on Gut Barrier Function. Mediators Inflamm 2019;2019:7028253. [PMID: 31780866 DOI: 10.1155/2019/7028253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Niemeyer-van der Kolk T, van der Wall HEC, Balmforth C, Van Doorn MBA, Rissmann R. A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. Br J Clin Pharmacol 2018;84:2178-93. [PMID: 29877593 DOI: 10.1111/bcp.13662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
15 Hrncirova L, Machova V, Trckova E, Krejsek J, Hrncir T. Food Preservatives Induce Proteobacteria Dysbiosis in Human-Microbiota Associated Nod2-Deficient Mice. Microorganisms 2019;7:E383. [PMID: 31548508 DOI: 10.3390/microorganisms7100383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
16 Reens AL, Cabral DJ, Liang X, Norton JE Jr, Therien AG, Hazuda DJ, Swaminathan G. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination. Front Immunol 2021;12:643255. [PMID: 34054810 DOI: 10.3389/fimmu.2021.643255] [Reference Citation Analysis]
17 Klingberg E, Magnusson MK, Strid H, Deminger A, Ståhl A, Sundin J, Simrén M, Carlsten H, Öhman L, Forsblad-d'Elia H. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res Ther 2019;21:248. [PMID: 31771630 DOI: 10.1186/s13075-019-2018-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
18 Álvarez-Mercado AI, Navarro-Oliveros M, Robles-Sánchez C, Plaza-Díaz J, Sáez-Lara MJ, Muñoz-Quezada S, Fontana L, Abadía-Molina F. Microbial Population Changes and Their Relationship with Human Health and Disease. Microorganisms 2019;7:E68. [PMID: 30832423 DOI: 10.3390/microorganisms7030068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
19 Iablokov SN, Novichkov PS, Osterman AL, Rodionov DA. Binary Metabolic Phenotypes and Phenotype Diversity Metrics for the Functional Characterization of Microbial Communities. Front Microbiol 2021;12:653314. [PMID: 34113324 DOI: 10.3389/fmicb.2021.653314] [Reference Citation Analysis]
20 Cullen CM, Aneja KK, Beyhan S, Cho CE, Woloszynek S, Convertino M, McCoy SJ, Zhang Y, Anderson MZ, Alvarez-Ponce D, Smirnova E, Karstens L, Dorrestein PC, Li H, Sen Gupta A, Cheung K, Powers JG, Zhao Z, Rosen GL. Emerging Priorities for Microbiome Research. Front Microbiol 2020;11:136. [PMID: 32140140 DOI: 10.3389/fmicb.2020.00136] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
21 Tan C, Wu Q, Wang H, Gao X, Xu R, Cui Z, Zhu J, Zeng X, Zhou H, He Y, Yin J. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes. JPEN J Parenter Enteral Nutr. 2020;. [PMID: 32473086 DOI: 10.1002/jpen.1861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kubinski R, Djamen-kepaou J, Zhanabaev T, Hernandez-garcia A, Bauer S, Hildebrand F, Korcsmaros T, Karam S, Jantchou P, Kafi K, Martin RD. Benchmark of Data Processing Methods and Machine Learning Models for Gut Microbiome-Based Diagnosis of Inflammatory Bowel Disease. Front Genet 2022;13:784397. [DOI: 10.3389/fgene.2022.784397] [Reference Citation Analysis]
23 Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr 2021;8:615064. [PMID: 33718417 DOI: 10.3389/fnut.2021.615064] [Reference Citation Analysis]
24 Li L, Chen R, Zhang Y, Zhou G, Chen B, Zeng Z, Chen M, Zhang S. A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease. Front Immunol 2021;12:646673. [PMID: 34367126 DOI: 10.3389/fimmu.2021.646673] [Reference Citation Analysis]
25 Chen HT, Huang HL, Xu HM, Luo QL, He J, Li YQ, Zhou YL, Nie YQ, Zhou YJ. Fecal microbiota transplantation ameliorates active ulcerative colitis. ExpTher Med. 2020;19:2650-2660. [PMID: 32256746 DOI: 10.3892/etm.2020.8512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
26 Tripathi A, Xu ZZ, Xue J, Poulsen O, Gonzalez A, Humphrey G, Meehan MJ, Melnik AV, Ackermann G, Zhou D, Malhotra A, Haddad GG, Dorrestein PC, Knight R. Intermittent Hypoxia and Hypercapnia Reproducibly Change the Gut Microbiome and Metabolome across Rodent Model Systems. mSystems 2019;4:e00058-19. [PMID: 31058230 DOI: 10.1128/mSystems.00058-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
27 Dovrolis N, Michalopoulos G, Theodoropoulos GE, Arvanitidis K, Kolios G, Sechi LA, Eliopoulos AG, Gazouli M. The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases. Microorganisms 2020;8:E438. [PMID: 32244928 DOI: 10.3390/microorganisms8030438] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
28 Wang T, Yu R, Zhu L, Wang X, Yang B. Differences in the Intestinal Flora of Patients with Inflammatory Bowel Disease in Southwest China. Indian J Microbiol. [DOI: 10.1007/s12088-022-01014-z] [Reference Citation Analysis]
29 Selmin OI, Papoutsis AJ, Hazan S, Smith C, Greenfield N, Donovan MG, Wren SN, Doetschman TC, Snider JM, Snider AJ, Chow SH, Romagnolo DF. n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic Inflammation. Int J Mol Sci 2021;22:6919. [PMID: 34203196 DOI: 10.3390/ijms22136919] [Reference Citation Analysis]
30 Marizzoni M, Gurry T, Provasi S, Greub G, Lopizzo N, Ribaldi F, Festari C, Mazzelli M, Mombelli E, Salvatore M, Mirabelli P, Franzese M, Soricelli A, Frisoni GB, Cattaneo A. Comparison of Bioinformatics Pipelines and Operating Systems for the Analyses of 16S rRNA Gene Amplicon Sequences in Human Fecal Samples. Front Microbiol 2020;11:1262. [PMID: 32636817 DOI: 10.3389/fmicb.2020.01262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
31 Seong G, Kim N, Joung JG, Kim ER, Chang DK, Chun J, Hong SN, Kim YH. Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle. Microorganisms 2020;8:E874. [PMID: 32527024 DOI: 10.3390/microorganisms8060874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Sanchis-Artero L, Martínez-Blanch JF, Manresa-Vera S, Cortés-Castell E, Valls-Gandia M, Iborra M, Paredes-Arquiola JM, Boscá-Watts M, Huguet JM, Gil-Borrás R, Rodríguez-Morales J, Cortés-Rizo X. Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatment. Sci Rep 2021;11:10016. [PMID: 33976272 DOI: 10.1038/s41598-021-88823-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Vaughn BP, Kaiser T, Staley C, Hamilton MJ, Reich J, Graiziger C, Singroy S, Kabage AJ, Sadowsky MJ, Khoruts A. A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis. Clin Exp Gastroenterol. 2019;12:9-19. [PMID: 30666146 DOI: 10.2147/ceg.s186097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
34 Sanchis-artero L, Martínez-blanch JF, Manresa-vera S, Cortés-castell E, Rodriguez-morales J, Cortés-rizo X. Evaluation of Changes in Gut Microbiota in Patients with Crohn’s Disease after Anti-Tnfα Treatment: Prospective Multicenter Observational Study. IJERPH 2020;17:5120. [DOI: 10.3390/ijerph17145120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Xu H, Liu M, Cao J, Li X, Fan D, Xia Y, Lu X, Li J, Ju D, Zhao H. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. J Immunol Res 2019;2019:7546047. [PMID: 31772949 DOI: 10.1155/2019/7546047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
36 Kang K, Sun Y, Pan D, Chang B, Sang LX. Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota. J Immunol Res 2021;2021:5084713. [PMID: 33748287 DOI: 10.1155/2021/5084713] [Reference Citation Analysis]
37 Zeichner SL, Mongodin EF, Hittle L, Huang SH, Torres C. The bacterial communities of the small intestine and stool in children with short bowel syndrome. PLoS One 2019;14:e0215351. [PMID: 31095575 DOI: 10.1371/journal.pone.0215351] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
38 Umanets A, Dinkla A, Vastenhouw S, Ravesloot L, Koets AP. Classification and prediction of Mycobacterium Avium subsp. Paratuberculosis (MAP) shedding severity in cattle based on young stock heifer faecal microbiota composition using random forest algorithms. Anim Microbiome 2021;3:78. [PMID: 34776001 DOI: 10.1186/s42523-021-00143-y] [Reference Citation Analysis]
39 Liang L, Liu L, Zhou W, Yang C, Mai G, Li H, Chen Y. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway. Clin Sci (Lond) 2022;136:291-307. [PMID: 35194640 DOI: 10.1042/CS20210778] [Reference Citation Analysis]
40 Xia GH, You C, Gao XX, Zeng XL, Zhu JJ, Xu KY, Tan CH, Xu RT, Wu QH, Zhou HW, He Y, Yin J. Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke. Front Neurol 2019;10:397. [PMID: 31068891 DOI: 10.3389/fneur.2019.00397] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
41 Cui G, Liu H, Xu G, Laugsand JB, Pang Z. Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:757025. [PMID: 34778319 DOI: 10.3389/fmed.2021.757025] [Reference Citation Analysis]
42 Dwiyanto J, Ayub Q, Lee SM, Foo SC, Chong CW, Rahman S. Geographical separation and ethnic origin influence the human gut microbial composition: a meta-analysis from a Malaysian perspective. Microb Genom 2021;7. [PMID: 34463609 DOI: 10.1099/mgen.0.000619] [Reference Citation Analysis]
43 Ke H, Li F, Deng W, Li Z, Wang S, Lv P, Chen Y. Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis. Front Pharmacol 2021;12:726707. [PMID: 34658866 DOI: 10.3389/fphar.2021.726707] [Reference Citation Analysis]
44 Bykova N, Litovka N, Popenko A, Musienko S. Pet-Human Gut Microbiome Host Classifier Using Data from Different Studies. Microorganisms 2020;8:E1591. [PMID: 33076521 DOI: 10.3390/microorganisms8101591] [Reference Citation Analysis]
45 Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Transl Res 2021;233:144-61. [PMID: 33515779 DOI: 10.1016/j.trsl.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM 3rd, Sung J. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med 2021;13:149. [PMID: 34517888 DOI: 10.1186/s13073-021-00957-0] [Reference Citation Analysis]
47 Gupta VK, Kim M, Bakshi U, Cunningham KY, Davis JM 3rd, Lazaridis KN, Nelson H, Chia N, Sung J. A predictive index for health status using species-level gut microbiome profiling. Nat Commun 2020;11:4635. [PMID: 32934239 DOI: 10.1038/s41467-020-18476-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
48 Wang Y, Gao X, Zhang X, Xiao F, Hu H, Li X, Dong F, Sun M, Xiao Y, Ge T, Li D, Yu G, Liu Z, Zhang T. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease. Gut Microbes 2021;13:1-18. [PMID: 33430702 DOI: 10.1080/19490976.2020.1865708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
49 Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 [PMID: 33521100 DOI: 10.12998/wjcc.v9.i2.321] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Xiong T, Zheng X, Zhang K, Wu H, Dong Y, Zhou F, Cheng B, Li L, Xu W, Su J, Huang J, Jiang Z, Li B, Zhang B, Lv G, Chen S. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway. J Ethnopharmacol 2022;289:115001. [PMID: 35085745 DOI: 10.1016/j.jep.2022.115001] [Reference Citation Analysis]
51 Zhu F, Ke Y, Luo Y, Wu J, Wu P, Ma F, Liu Y. Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats. Front Microbiol 2021;12:683234. [PMID: 34335508 DOI: 10.3389/fmicb.2021.683234] [Reference Citation Analysis]
52 Singh H, Clarke T, Brinkac L, Greco C, Nelson KE. Forensic Microbiome Database: A Tool for Forensic Geolocation Meta-Analysis Using Publicly Available 16S rRNA Microbiome Sequencing. Front Microbiol 2021;12:644861. [PMID: 33833745 DOI: 10.3389/fmicb.2021.644861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Witte M, Thaçi D. [Psoriasis and the microbiome]. Hautarzt 2019;70:416-21. [PMID: 31076813 DOI: 10.1007/s00105-019-4415-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
54 He H, Xu H, Xu J, Zhao H, Lin Q, Zhou Y, Nie Y. Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice. Front Nutr 2020;7:604283. [PMID: 33262998 DOI: 10.3389/fnut.2020.604283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Wang X, Xiao Y, Xu X, Guo L, Yu Y, Li N, Xu C. Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:711884. [PMID: 34950604 DOI: 10.3389/fcimb.2021.711884] [Reference Citation Analysis]
56 Moris G, Arboleya S, Mancabelli L, Milani C, Ventura M, de Los Reyes-Gavilán CG, Gueimonde M. Fecal microbiota profile in a group of myasthenia gravis patients. Sci Rep 2018;8:14384. [PMID: 30258104 DOI: 10.1038/s41598-018-32700-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
57 Kaczmarczyk M, Löber U, Adamek K, Węgrzyn D, Skonieczna-Żydecka K, Malinowski D, Łoniewski I, Markó L, Ulas T, Forslund SK, Łoniewska B. The gut microbiota is associated with the small intestinal paracellular permeability and the development of the immune system in healthy children during the first two years of life. J Transl Med 2021;19:177. [PMID: 33910577 DOI: 10.1186/s12967-021-02839-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yeh NL, Hsu CY, Tsai TF, Chiu HY. Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment. Clin Drug Investig 2019;39:1195-203. [PMID: 31549347 DOI: 10.1007/s40261-019-00849-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
59 Privitera G, Pugliese D, Rapaccini GL, Gasbarrini A, Armuzzi A, Guidi L. Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases. J Clin Med 2021;10:853. [PMID: 33669579 DOI: 10.3390/jcm10040853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Odintsova VE, Klimenko NS, Tyakht AV, Gilbert JA. Approximation of a Microbiome Composition Shift by a Change in a Single Balance Between Two Groups of Taxa. mSystems. [DOI: 10.1128/msystems.00155-22] [Reference Citation Analysis]
61 Chen Z, Zheng X, Wu X, Wu J, Li X, Wei Q, Zhang X, Fang L, Jin O, Gu J. Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis. Front Immunol 2021;12:700570. [PMID: 34539629 DOI: 10.3389/fimmu.2021.700570] [Reference Citation Analysis]
62 Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, Festen EAM, Wijmenga C, Jonkers DMAE, Dijkstra G, Fu J, Zhernakova A, Imhann F, Weersma RK. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 2021;13:1943288. [PMID: 34313538 DOI: 10.1080/19490976.2021.1943288] [Reference Citation Analysis]
63 Zhuang Z, Li N, Wang J, Yang R, Wang W, Liu Z, Huang T. GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur J Clin Nutr. [DOI: 10.1038/s41430-022-01074-w] [Reference Citation Analysis]
64 Zhao X, Tang W, Wan H, Lan Z, Qin H, Lin Q, Hu Y, Yu G, Jiang N, Yu B. Altered Gut Microbiota as an Auxiliary Diagnostic Indicator for Patients With Fracture-Related Infection. Front Microbiol 2022;13:723791. [DOI: 10.3389/fmicb.2022.723791] [Reference Citation Analysis]
65 Tataru CA, David MM. Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease. PLoS Comput Biol 2020;16:e1007859. [PMID: 32365061 DOI: 10.1371/journal.pcbi.1007859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
66 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis 2019;25:1927-38. [PMID: 31276165 DOI: 10.1093/ibd/izz130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
67 Castro F, de Souza HSP. Dietary Composition and Effects in Inflammatory Bowel Disease. Nutrients 2019;11:E1398. [PMID: 31234325 DOI: 10.3390/nu11061398] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
68 Chowers Y. One Size Does Not Fit All: The Case for Translational Medicine. Rambam Maimonides Med J 2019;10. [PMID: 30860477 DOI: 10.5041/RMMJ.10364] [Reference Citation Analysis]
69 Zhou Y, Xu H, Xu J, Guo X, Zhao H, Chen Y, Zhou Y, Nie Y. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis. AMB Express 2021;11:33. [PMID: 33641084 DOI: 10.1186/s13568-021-01197-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Li MX, Li MY, Lei JX, Wu YZ, Li ZH, Chen LM, Zhou CL, Su JY, Huang GX, Huang XQ, Zheng XB. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier. Phytomedicine 2022;100:154052. [PMID: 35344714 DOI: 10.1016/j.phymed.2022.154052] [Reference Citation Analysis]
71 Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R. Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians. Clin Gastroenterol Hepatol 2019;17:218-30. [PMID: 30240894 DOI: 10.1016/j.cgh.2018.09.017] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 18.8] [Reference Citation Analysis]